Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novel ibuprofen sodium vs standard ibuprofen for post-surgical dental pain (Study I)
2014-004176-35Phase 3
- Sponsor
- Pfizer
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ibuprofen in odontalgia (4 arms), sponsored by Pfizer. Primary endpoint: Time-weighted Sum of Pain Relief Rating and Pain Intensity Difference From 0-8 Hours (SPRID 0-8).
02
Drugs
ibuprofen
03
Conditions
odontalgia
Beyond the preview
Go deeper on 2014-004176-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004176-35.